CYBERDYNE

• Medical HAL Lower Limb Type

  HAL

• 7779.T - TSE Growth - JPY

• Yoshiyuki Sankai - Founder, President and CEO

• HAL study on neuroplasticity and therapeutic benefit is published in an international medical journal

  2025-06-26 - Research Publication - CYBERDYNE announced that HAL was identified in a systematic review as the only exoskeleton device inducing neuroplasticity while providing broad therapeutic benefits across spinal cord injury outcomes. The review was published in the June 2025 issue of Global Spine Journal and analyzed 27 clinical studies covering 591 spinal cord injury patients. CYBERDYNE tied the findings to HAL''s interactive biofeedback approach, which uses real-time bioelectrical signals to support voluntary movement.

  Source

Events

• 2026-06-16 - Market Signal - CYBERDYNE and Pegasus launch JPY 10B Physical AI CVC fund

  Pegasus is the general partner and CYBERDYNE is the sole limited partner. The fund is capital-infrastructure context for robotics and Physical AI rather than a direct product or deployment event.

  Source
• 2026-01-21 - Partnership - CYBERDYNE signs strategic MoU with Carnegie Mellon University

  CYBERDYNE announced a strategic memorandum of understanding with Carnegie Mellon University to accelerate research, education, and social implementation in the United States. The collaboration was framed around Cybernics, AI, robotics, and medical-healthcare innovation linked to the Pittsburgh ecosystem. The agreement positions CYBERDYNE to deepen its U.S. research and translational footprint beyond product distribution alone.

  Source
• 2026-01-14 - Partnership - CYBERDYNE and Thailand's Institute of Geriatric Medicine agree ASEAN healthcare innovation MoU

  CYBERDYNE signed an MoU with Thailand''s Institute of Geriatric Medicine under the Department of Medical Services to promote Cybernics medical and healthcare innovation across ASEAN. The agreement followed a 2025 visit by Thailand''s Ministry of Public Health delegation and positioned CYBERDYNE as a strategic partner for aging-related healthcare challenges. The parties said the collaboration would support clinical development, human resource development, and broader regional social implementation.

  Source
• 2025-06-26 - Research Publication - HAL study on neuroplasticity and therapeutic benefit is published in an international medical journal

  CYBERDYNE announced that HAL was identified in a systematic review as the only exoskeleton device inducing neuroplasticity while providing broad therapeutic benefits across spinal cord injury outcomes. The review was published in the June 2025 issue of Global Spine Journal and analyzed 27 clinical studies covering 591 spinal cord injury patients. CYBERDYNE tied the findings to HAL''s interactive biofeedback approach, which uses real-time bioelectrical signals to support voluntary movement.

  Source
• 2025-06-18 - Partnership - CYBERDYNE signs MoU with National Taiwan University and the University of Tsukuba

  CYBERDYNE signed a memorandum of understanding with National Taiwan University and the University of Tsukuba for international collaboration in Cybernics medical healthcare innovation. The collaboration brings together medicine, AI, robotics, and cybernics research teams to advance research cooperation and social implementation in Taiwan and Japan. The agreement reinforces CYBERDYNE''s strategy of building clinical and academic partnerships around its healthcare robotics platform.

  Source
• 2025-01-31 - Regulatory - CYBERDYNE obtains Japanese approval for small-size model of Medical HAL

  CYBERDYNE obtained certification in Japan to manufacture and sell the small-size model of Medical HAL Lower Limb Type B. The approval expands access to Cybernics Treatment for patients from 100 cm to 150 cm who were previously outside the device''s size range. CYBERDYNE said the smaller model is now approved across the U.S., Europe, and Japan, strengthening the product''s position in the three major medical-device markets.

  Source
• 2024-12-10 - Product Launch - CYBERDYNE launches Medical Vital Sensor Cyvis M100 with Japan medical-device clearance and insurance coverage

  CYBERDYNE announced the new Medical Vital Sensor Cyvis M100 after obtaining Japanese medical-device certification on November 27, 2024. The Ministry of Health, Labour and Welfare also accepted the company''s request for public health insurance coverage in Japan as of the announcement date. The event marked expansion beyond HAL into medical sensing hardware tied to CYBERDYNE''s broader Cybernics healthcare platform.

  Source

Relationships

• Carnegie Mellon University

  Academic And Research Partner - CYBERDYNE and Carnegie Mellon signed an MOU for Cybernics, AI, robotics and medical-healthcare research.

• Institute of Geriatric Medicine, Department of Medical Services, Ministry of Public Health of Thailand

  Healthcare Innovation Partner (asean) - MoU with Thailand's Institute of Geriatric Medicine (Department of Medical Services) for Cybernics medical and healthcare innovation across ASEAN.

• University of Tsukuba

  Academic Partner - Memorandum of understanding for Cybernics medical healthcare innovation with the University of Tsukuba.

Comparable profiles

• Chengtian Technology (程天科技)

  comparable profile - Medical Exoskeletons

• Ekso Bionics

  comparable profile - Medical Exoskeletons

• Wandercraft

  comparable profile - Medical Exoskeletons

• Fourier Intelligence

  comparable profile - Medical Exoskeletons

• Wearable Robotics

  comparable profile - Medical Exoskeletons

• BrainCo

  comparable profile - Intent Based Motion Control · Powered Limb Assistance

Shared workflows

• Marsi Bionics

  workflow adjacency - Rehabilitation Robotics

• Trexo Robotics

  workflow adjacency - Rehabilitation Robotics

• REEV

  workflow adjacency - Rehabilitation Robotics

• Reactive Robotics

  workflow adjacency - Rehabilitation Robotics

• Human Robotix

  workflow adjacency - Rehabilitation Robotics

• Humotech

  workflow adjacency - Rehabilitation Robotics

Context tags

• Rehabilitation robotics workflow - Workflow - CYBERDYNE develops HAL rehabilitation robotic exoskeletons.
• Medical exoskeletons - Peer Group - HAL is a powered medical exoskeleton for gait and limb rehabilitation.
• Gait rehabilitation - Workflow - HAL supports gait rehabilitation and walking recovery.
• Powered limb assistance - Capability - HAL provides powered limb assistance for impaired lower-limb function.
• Intent-based motion control - Capability - HAL uses bioelectric intent-based motion control from muscle signals.
• Rehabilitation robotics platform - Stack Layer - CYBERDYNE provides a rehabilitation robotics platform.
• Medical robot OEM - Stack Layer - CYBERDYNE builds complete HAL exoskeleton robotic systems.
• Rehabilitation clinics - Customer Environment - HAL is deployed in rehabilitation clinics and hospital therapy settings.